CytoDyn Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CytoDyn Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • CytoDyn Inc. Return On Equity for the quarter ending August 31, 2024 was 17.5 %, a 72.1% decline year-over-year.
  • CytoDyn Inc. annual Return On Equity for 2023 was 46.7 %, a 77.4% decline from 2022.
  • CytoDyn Inc. annual Return On Equity for 2022 was 206 %, a 90.1% decline from 2021.
  • CytoDyn Inc. annual Return On Equity for 2021 was 2.08K %, a 19.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 46.7 -160 -77.4% Jun 1, 2023 May 31, 2024
2022 206 -1.87K -90.1% Jun 1, 2022 May 31, 2023
2021 2.08K -508 -19.7% Jun 1, 2021 May 31, 2022
2020 2.59K +1.29K +98.8% Jun 1, 2020 May 31, 2021
2019 1.3K +721 +124% Jun 1, 2019 May 31, 2020
2018 580 +1.84K Jun 1, 2018 May 31, 2019
2017 -1.26K -399 -46.4% Jun 1, 2017 May 31, 2018
2016 -860 -1.53K -229% Jun 1, 2016 May 31, 2017
2015 668 +1.18K Jun 1, 2015 May 31, 2016
2014 -508 -1.51K -151% Jun 1, 2014 May 31, 2015
2013 1K +800 +391% Jun 1, 2013 May 31, 2014
2012 205 Jun 1, 2012 May 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.